All Stories

  1. Relevance of Sustainable and Green-Synthesized Biogenic Iron Oxide Nanoparticles for Remediation of Emerging Contaminants from Water Ecosystems and Their Associated Health Concerns
  2. Targeting the tumor microenvironment and mitochondrial dynamics: A theranostic frontier in cancer
  3. Mapping The Pathways of Breast Cancer: Molecular Insights and Therapeutic Opportunities
  4. Polyherbal Formulation Attenuates Isoproterenol-Induced Cardiac Toxicity Through Regulation of Mitochondrial Bioenergetics, Lipid Toxicity, and Intrinsic Apoptotic Pathways in Rats
  5. Epithelial–mesenchymal transition and cancer-associated fibroblasts in tumor progression and therapy resistance: mechanistic convergence and therapeutic opportunities
  6. Toxicomicrobiomics: Unveiling the Role of Human Microbiome in Drug and Xenobiotic Metabolism
  7. Advancement in CAR T-Cell Therapy in Tumors
  8. Adverse Effects of CAR T-Cell Therapy and Management: Cytokine Release Syndrome and Neurotoxicity
  9. Clinical Success of CAR T Cells in Hematologic Cancers: Lessons from Leukemia and Lymphoma
  10. Combining CAR T Cells with Immunotherapies to Enhance Treatment Effectiveness
  11. Engineering CAR T Cells: Advances in Vector Design and Gene Editing
  12. From Bench to Bedside: Innovations and Challenges in CAR-T Cell Therapy Manufacturing and Regulation
  13. History and Evolution of CAR T-Cell Therapy
  14. Next-Generation CARs and Beyond: Synthetic Biology and Logic-Gates in Next-Generation CARs
  15. Optimizing CAR T-Cell Efficacy: Enhancing Proliferation, Persistence, and Memory
  16. Overcoming Challenges of CAR T-Cell Therapy in Solid Tumor Microenvironments
  17. Personalized CAR T-Cell Therapy: Tailoring to Patient-Specific Tumors
  18. Regulatory Landscape and Challenges in CAR-T Cell Therapy Development and Clinical Trials
  19. Biomarkers for targeted therapy and treatment decision making
  20. Cancer biomarker that are currently used in cancer therapy and under evaluation in clinical trials
  21. Biomarkers for cancer screening, diagnosis and targeted therapeutic approaches
  22. Classification of cancer biomarkers based on treatment strategies
  23. Future perspectives and challenges for identification and recognition of clinically significant cancer biomarkers
  24. Patient-centric approaches and personalized nanomedicine in skin cancer
  25. Emerging therapeutic approaches in neurobiology of type 2 diabetes
  26. Neural regulation of glucose homeostasis
  27. NANOG: A key element for reverse aging
  28. Reverse aging through immune driven signaling
  29. Epigenetic Therapy by Phytochemicals in Lung Cancer
  30. Epigenetic therapy by phytochemicals in lung cancer: Mechanism, therapeutic potential, and clinical implications
  31. Aging: Concept, theories, principle and future prospective
  32. Alkaloids and lung cancer epigenetics: Mechanistic insights and case studies
  33. Cancer immunotherapy, including CAR-T cell therapy and immune checkpoint inhibitors
  34. Challenges in phytochemical-based epigenetic therapy
  35. Combination therapies: Phytochemicals with conventional lung cancer therapies
  36. Conclusion and future perspectives in epigenetic phytotherapy for lung cancer
  37. DNA methylation modulation by phytochemicals
  38. Fungal Secondary Metabolites as Antibiotics
  39. Impact of phytochemicals on noncoding RNAs in lung cancer
  40. Insights into clinical trials and real-world applications of phytochemicals
  41. Introduction to phytochemicals with epigenetic activity
  42. Nature’s epigenetic tools: Histone modification control by phytochemicals in lung cancer
  43. Polyphenols as epigenetic modulators: Curcumin, resveratrol, and quercetin
  44. Preclinical and clinical trials of phytochemicals in lung cancer epigenetics
  45. Terpenoids and their role in lung cancer epigenetic modulation
  46. Combination of hydroxycitric acid and capsaicin regulates IRS-1/AMPK-mTOR-SREBP-1c Axis/NLRP3-NF-κB/Nrf-2-ARE signaling pathways to ameliorate the two-hit process in high-fat diet-induced hepatic steatosis
  47. Integrating CAR-T cells with other Immunotherapies for improved efficacy in cancer patients
  48. The Mediating Role of the Gut Microbiome in the Nutritional Prevention of Cancer
  49. Activated protein C promotes human lung cancer progression through the release of tumor extracellular vesicles and transfer of microRNA-200a
  50. Application and Prospects of Nanotechnology for Water Treatment
  51. Current Status and Future Prospects of Nanotechnology in the Healthcare Industry
  52. Regulatory dynamics of Th17 lymphocytes in oral squamous cell carcinoma: immune modulation and emerging immunotherapies
  53. Tumor microenvironment in breast cancer: cellular crosstalk, pathways, and therapeutic insights
  54. Molecular approaches of phytoremediation – a strategic regulator for pollution management
  55. Dissecting dietary hazards: cytogenotoxic impacts of monosodium glutamate, baking powder, and citric acid using Allium cepa assay
  56. Extracellular vesicles in acute myeloid leukemia: The role in disease pathogenesis, potential biomarker, and application in clinical settings
  57. Natural Products and their Bioactive Compounds for the Prevention and Treatment of Diabetes Mellitus: A Systematic Review
  58. Prevalence of Cancer in India with Respect to Leukaemia and their Factorial Relations
  59. Nanoplatforms for precision imaging and targeted therapy in oncology
  60. Beyond coagulation: Coagulation protease factor VIIa in cytoprotective response
  61. Frontiers in superbug management: innovating approaches to combat antimicrobial resistance
  62. Detection Methods in HPV-Related Cancers
  63. CAR T-Cell Therapies against Viral Oncogenesis
  64. Cytomegalovirus (CMV)
  65. Difficulties in Promptly Diagnosing and Treating Neonatal Herpes Simplex Virus Infection
  66. Global Epidemiology of Oncogenic Viral Infections
  67. Hepatitis B Virus Infection
  68. Host–Viral Interactions during Oncogenic Infections
  69. Human T-Cell Leukemia Virus (HTLV)-Induced Carcinogenesis and Its Molecular Detection
  70. Immune Response Associated with Oncogenic Viral Diseases
  71. Laboratory Animal Model for Oncogenic Virus
  72. Malignant Transformation In Vitro by Oncogenic Viruses
  73. Molecular Cancer Drug Discovery
  74. Types of Viral Oncogenic Viral Diseases
  75. Vaccines
  76. Viral Oncology
  77. Evaluation of Bloodstream Infections Associated with Carbapenem-Resistant Enterobacteriaceae in Paediatric and Adult Patients
  78. Epigenetic analysis in cancer research
  79. Gene therapies for neurodegenerative disease: current knowledge and challenges
  80. Gene therapy under clinical trials for neurodegenerative diseases
  81. Introduction to cancer biology and current research trends
  82. Transgene delivery system: viral, nonviral, and other methods for central nervous system
  83. Emerging biomarkers for non-invasive cancer diagnosis and treatment
  84. Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis
  85. Method Optimization and Validation of Antibiotics Residues in Milk Sample Using LC-MS/MS
  86. The role of extracellular vesicles in the pathogenesis of gynecological cancer
  87. MicroRNAs in extracellular vesicles: A potential role in cancer progression
  88. Development of New Screening Methods for SARS CoV 2 and its Associated Developing Variations
  89. Diagnosis and Treatment of Health Effects Caused by Airborne Contaminants
  90. Development of Personalized Medicine
  91. Nanobiotechnology in Personalized Oncology
  92. Phytoformulation with hydroxycitric acid and capsaicin protects against high-fat-diet-induced obesity cardiomyopathy by reducing cardiac lipid deposition and ameliorating inflammation and apoptosis in the heart
  93. Astroviruses: Overview and Emerging Disease
  94. Molecular Mechanisms of Human Papillomavirus-Induced Cervical Carcinogenesis
  95. Immunogenicity of cancer cells: An overview
  96. Risk Prediction and Diagnosis of Breast Cancer Using ML Algorithms
  97. CAR T-cell therapy: Reprogramming patient's immune cell to treat cancer
  98. An Updated Review on Influenza Viruses
  99. Avian Influenza: A Potential Threat to Human Health
  100. Crimean-Congo Haemorrhagic Fever Virus: A Complete Overview
  101. Novel Diagnostic Methods for Emerging Respiratory Viral Infection
  102. RAS: Circuitry and therapeutic targeting
  103. Effect of Allium Sativum on the Alcohol Induced Neuropathic Pain in Wistar Rats
  104. Cardiovascular Diseases and Nutraceuticals: Underlying Mechanism and Therapeutic Biomarkers
  105. Epigenetic Regulation of Breast Cancer
  106. Microbial indicators and methods for source tracking faecal contamination of groundwater
  107. Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope
  108. Expression profile of MUC1 protein in Pigeon allergens positive asthmatic
  109. Current updates on adaptive immune response by B cell and T cell stimulation and therapeutic strategies for novel coronavirus disease 2019 (COVID-19) treatment
  110. Phytopharmaceuticals in Cancer Treatment
  111. Epigenetic Regulation of Breast Cancer
  112. Research Article Non-synonymous de novo gene mutations in Wilms’ Tumor: Identification and characterization of new variants of WT1 and WT2 loci in Indian Population
  113. Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype
  114. Reversal of hypermethylation and reactivation of glutathione S -transferase pi 1 gene by curcumin in breast cancer cell line
  115. Breast cancer and human papillomavirus infection: No evidence of HPV etiology of breast cancer in Indian women